Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-03
1998-02-17
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514400, 514407, 514427, 546332, 5483361, 5483751, 548561, C07D21302, A61K 3144
Patent
active
057191697
ABSTRACT:
The invention relates to benzoylguanidines of the formula I: ##STR1## to pharmaceutically acceptable salts of these compounds and to a process for preparing compounds of the formula I, which comprise reacting a compound of the formula II ##STR2## with guanidine. The compounds of the invention are suitable as antiarrhythmic pharmaceuticals having a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris.
REFERENCES:
patent: 3780027 (1973-12-01), Cragoe et al.
patent: 5091394 (1992-02-01), Englert et al.
patent: 5292755 (1994-03-01), Englert et al.
Derwent Abstract of WO 93/04048, 1993.
A. Schomig et al., "Inhibition of Na.sup.+ /H.sup.+ exchange suppresses noradrenaline release and arrhythmias in the ischemic rat heart, " Eur. Heart J. 9(suppl. 1): 167 (1988), Book of abstracts.
Albus Udo
Kleemann Heinz-Werner
Lang Hans-Jochen
Scholz Wolfgang
Schwark Jan-Robert
Davis Zinna Northington
Hoechst Aktiengesellschaft
LandOfFree
Substituted benzoylguanidines, their use as a medicament or diag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzoylguanidines, their use as a medicament or diag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoylguanidines, their use as a medicament or diag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784325